Laboratory Considerations for Clinical Trials
Science:Life Sciences
In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage both scientific and operational risk in clinical trials for biotech companies.
Looking at risk as uncertainty reveals not only threats to project timelines but also opportunities to take a new approach.
Alex and Alan talk about:
- How different risks are evaluated and prioritized and the processes put in place to mitigate and/or respond to those risks if they occur.
- What sponsors can do to reduce the risks for their study
- How Q2 Solutions' in-house scientific and regulatory expertise ensure that your data are compliant to global regulations
You can learn more at https://q2labsolutions.com/biotech.
More Episodes
Managing Sample Data from Vendors
2021-09-15
156
2021-09-15
156
Automation within an ADME Laboratory
2021-08-26
157
2021-08-26
157
Bioanalytical Automation of Samples
2021-07-30
117
2021-07-30
117
Consent Tracking for Clinical Samples
2021-07-28
130
2021-07-28
130
Tracking Clinical Trial Samples
2021-07-28
121
2021-07-28
121
Avoiding Canceled Tests in Pediatric Samples
2021-02-02
128
2021-02-02
128
Covid Vaccine Testing
2020-09-15
170
2020-09-15
170
Hybrid Assays for Protein Bioanalysis
2020-07-29
126
2020-07-29
126
High Throughput ADME Testing
2020-07-29
80
2020-07-29
80
Liquid Biopsy Collection in Clinical Development Programs
2020-07-29
104
2020-07-29
104
Companion Diagnostic Strategies for Commercial Success
2019-02-26
138
2019-02-26
138
Bioanalysis for Immuno-oncology - Dr. Mike Brown
2019-02-12
68
2019-02-12
68
Get this podcast on your
phone, FREE
Create your
podcast in
minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Integrate with iTunes and Google
store - Make money with your podcast
It is Free
